Moderna expects to start late-stage COVID-19 vaccine trial on July 27

Credit: REUTERS/Brian Snyder

NEW YORK, July 14 (Reuters) - Moderna Inc MRNA.O said on Tuesday that it plans to start late stage clinical trial for its COVID-19 vaccine candidate on or around July 27, according to its listing for the phase 3 study at

Moderna said it will conduct the trial at 87 study locations, all in the U.S.

(Reporting by Michael Erman, Editing by Franklin Paul)

((; +1 646-223-6021; Reuters Messaging:

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.


More Related Articles

Sign up for Smart Investing to get the latest news, strategies and tips to help you invest smarter.